Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Dec;82(6):1939–1947. doi: 10.1172/JCI113813

Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes.

P Xia 1, R E Jordon 1, W D Geoghegan 1
PMCID: PMC442775  PMID: 2461964

Abstract

Previous studies have shown that pemphigus vulgaris (PV) IgG will fix early complement components (C1q, C4, and C3) to cultured murine epidermal cell surfaces and that PV IgG and complement alter epidermal cell membrane integrity. The present study was undertaken to determine if assembly of terminal complement components (C5, C6, C7, C8, and C9) and expression of C5b-9 neoantigens occur when PV IgG interacts with human keratinocyte (HuK) cell surface antigens in the presence of a source of complement. Monoclonal antibodies specific for C5, C6, C7, C8, C9, and C5b-9 neoantigens were screened for reactivity to the individual complement components in an assembled complex of human C5b-9 on rabbit red blood cell ghosts. Monoclonal antibodies (tissue culture supernatants) that bound to antigenic determinants accessible in the C5b-9 complex were selected for this study using immunofluorescence methods. HuK treated with PV IgG fixed C5, C6, C7, C8, C9, and C5b-9 neoantigens in a characteristic speckled pattern, while normal IgG did not. Heat inactivation or EDTA treatment of the complement source, or substitution of C2-depleted serum abolished C5, C6, C7, C8, C9, and C5b-9 neoantigen staining. PV IgG and complement also resulted in significant cytotoxicity to cell membranes as assessed using an ethidium bromide-fluorescein diacetate assay. These results suggest that PV IgG will activate the membrane attack complex of the complement system on HuK cell surfaces, resulting in cytotoxicity to cell membranes, further implicating complement in the pathogenesis of pemphigus.

Full text

PDF
1939

Images in this article

1940Image
on p.1940
1940Image
on p.1940
1941Image
on p.1941
1942Image
on p.1942
1942Image
on p.1942
1943Image
on p.1943
1944Image
on p.1944
1944Image
on p.1944
1945Image
on p.1945

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEUTNER E. H., JORDON R. E. DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING. Proc Soc Exp Biol Med. 1964 Nov;117:505–510. doi: 10.3181/00379727-117-29622. [DOI] [PubMed] [Google Scholar]
  2. Biesecker G., Müller-Eberhard H. J. The ninth component of human complement: purification and physicochemical characterization. J Immunol. 1980 Mar;124(3):1291–1296. [PubMed] [Google Scholar]
  3. Dankberg F., Persidsky M. D. A test of granulocyte membrane integrity and phagocytic function. Cryobiology. 1976 Aug;13(4):430–432. doi: 10.1016/0011-2240(76)90098-5. [DOI] [PubMed] [Google Scholar]
  4. Diaz L. A., Marcelo C. L. Pemphigoid and pemphigus antigens in cultured epidermal cells. Br J Dermatol. 1978 Jun;98(6):631–637. doi: 10.1111/j.1365-2133.1978.tb03581.x. [DOI] [PubMed] [Google Scholar]
  5. Doubleday C. W., Geoghegan W. D., Jordon R. E. Complement fixation by pemphigus antibody. IV. Enhanced epidermal cell detachment in the absence of human plasminogen. J Lab Clin Med. 1988 Jan;111(1):28–34. [PubMed] [Google Scholar]
  6. Engvall E. Enzyme immunoassay ELISA and EMIT. Methods Enzymol. 1980;70(A):419–439. doi: 10.1016/s0076-6879(80)70067-8. [DOI] [PubMed] [Google Scholar]
  7. Hashimoto T., Sugiura M., Kurihara S., Nishikawa T. In vitro complement activation by intercellular antibodies. J Invest Dermatol. 1982 Apr;78(4):316–318. doi: 10.1111/1523-1747.ep12507396. [DOI] [PubMed] [Google Scholar]
  8. Jordan R. E., Day N. K., Luckasen J. R., Good R. A. Complement activation in pemphigus vulgaris blister fluid. Clin Exp Immunol. 1973 Sep;15(1):53–63. [PMC free article] [PubMed] [Google Scholar]
  9. Jordon R. E., Sams W. M., Jr, Diaz G., Beutner E. H. Negative complement immunofluorescence in pemphigus. J Invest Dermatol. 1971 Dec;57(6):407–410. doi: 10.1111/1523-1747.ep12293273. [DOI] [PubMed] [Google Scholar]
  10. Jordon R. E., Schroeter A. L., Rogers R. S., 3rd, Perry H. O. Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J Invest Dermatol. 1974 Sep;63(3):256–259. doi: 10.1111/1523-1747.ep12680098. [DOI] [PubMed] [Google Scholar]
  11. Kawana S., Geoghegan W. D., Jordon R. E. Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells. Clin Exp Immunol. 1985 Sep;61(3):517–525. [PMC free article] [PubMed] [Google Scholar]
  12. Kawana S., Geoghegan W. D., Jordon R. E. Complement fixation by pemphigus antibody. III. Altered epidermal cell membrane integrity mediated by pemphigus antibody and complement. J Invest Dermatol. 1986 Jan;86(1):29–33. doi: 10.1111/1523-1747.ep12283762. [DOI] [PubMed] [Google Scholar]
  13. Kawana S., Janson M., Jordon R. E. Complement fixation by pemphigus antibody. I. In vitro fixation to organ and tissue culture skin. J Invest Dermatol. 1984 May;82(5):506–510. doi: 10.1111/1523-1747.ep12261058. [DOI] [PubMed] [Google Scholar]
  14. Kolb W. P., Kolb L. M., Savary J. R. Biochemical characterization of the sixth component (C6) of human complement. Biochemistry. 1982 Jan 19;21(2):294–301. doi: 10.1021/bi00531a015. [DOI] [PubMed] [Google Scholar]
  15. Kolb W. P., Muller-Eberhard H. J. The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex. J Exp Med. 1975 Apr 1;141(4):724–735. [PMC free article] [PubMed] [Google Scholar]
  16. Müller-Eberhard H. J. The killer molecule of complement. J Invest Dermatol. 1985 Jul;85(1 Suppl):47s–52s. doi: 10.1111/1523-1747.ep12275445. [DOI] [PubMed] [Google Scholar]
  17. Nishikawa T., Kurihara S., Harada T., Sugawara M., Hatano H. Capability of complement fixation of pemphigus antibodies in vitro. Arch Dermatol Res. 1977 Oct 27;260(1):1–6. doi: 10.1007/BF00558008. [DOI] [PubMed] [Google Scholar]
  18. Podack E. R., Kolb W. P., Esser A. F., Müller-Eberhard H. J. Structural similarities between C6 and C7 of human complement. J Immunol. 1979 Sep;123(3):1071–1077. [PubMed] [Google Scholar]
  19. Podack E. R., Müller-Eberhard H. J. SC5b-9 complex of complement: formation of the dimeric membrane attack complex by removal of S-protein. J Immunol. 1980 Apr;124(4):1779–1783. [PubMed] [Google Scholar]
  20. Schiltz J. R., Michel B., Papay R. Pemphigus antibody interaction with human epidermal cells in culture. J Clin Invest. 1978 Oct;62(4):778–788. doi: 10.1172/JCI109189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stanley J. R., Yuspa S. H. Specific epidermal protein markers are modulated during calcium-induced terminal differentiation. J Cell Biol. 1983 Jun;96(6):1809–1814. doi: 10.1083/jcb.96.6.1809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Steckel E. W., York R. G., Monahan J. B., Sodetz J. M. The eighth component of human complement. Purification and physicochemical characterization of its unusual subunit structure. J Biol Chem. 1980 Dec 25;255(24):11997–12005. [PubMed] [Google Scholar]
  23. Twining S. S. Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes. Anal Biochem. 1984 Nov 15;143(1):30–34. doi: 10.1016/0003-2697(84)90553-0. [DOI] [PubMed] [Google Scholar]
  24. Wetsel R. A., Jones M. A., Kolb W. P. Immunoadsorbent affinity purification of the fifth component (C5) of human complement and development of a highly sensitive hemolytic assay. J Immunol Methods. 1980;35(3-4):319–335. doi: 10.1016/0022-1759(80)90258-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES